Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Salaries and benefits

Supplies

Other operating expenses

Equity in earnings of affiliates

Depreciation and amortization

Interest expense

Gains on sales of facilities

Losses on retirement of debt

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

HCA Healthcare

HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

HCA Healthcare reports robust Q4 performance and outlines strategic growth

HCA Healthcare's Q4 2022 performance reflects strong same-facility volumes, stable labor costs, and strategic investments in growth areas.
The company's focus on overcoming challenges, leveraging strengths, and seizing opportunities positions them for sustainable growth and operational excellence.
With a clear agenda for 2023, including revenue guidance and investment plans, HCA Healthcare aims to navigate market dynamics and drive value creation.
By addressing key performance metrics, managing costs effectively, and pursuing strategic initiatives, HCA Healthcare demonstrates a commitment to long-term success.

HCA Healthcare reports robust Q1 earnings amidst operational enhancements

HCA Healthcare delivered strong financial performance with notable growth in key metrics and operational efficiency improvements.
While facing challenges from COVID-related impacts and procedural shifts, the company is focused on maintaining positive volume trends and managing costs effectively.
Opportunities lie in investing in capabilities, capacity improvement, and navigating contract renewals in an inflationary environment.

HCA Healthcare reports robust Q2 earnings amidst strategic investments

HCA Healthcare's Q2 2023 performance reflects strong earnings, revenue growth, and cash flow, supported by strategic investments.
While facing challenges like margin impact from acquisitions and rising capital spending, the company is well-positioned for growth.
Opportunities lie in optimizing labor costs, expanding services, and leveraging positive payer mix trends for sustained success.
Overall, HCA's focus on quality care, financial prudence, and growth initiatives underpins a positive outlook for the future.

HCA Healthcare manages challenges, eyes sustained growth amid revenue optimizations

HCA Healthcare navigated challenges from the Valesco venture to deliver solid financial performance. The company's focus on quality care, cost management, and revenue optimization positions it for sustained growth. Anticipation of improved margins, strategic growth discussions, and operational enhancements highlight a positive outlook for the future.

HCA Healthcare reports robust Q4 earnings and outlines growth strategies

HCA Healthcare's strong Q4 performance and strategic investments position it well for growth in 2024, with a focus on cost management and operational efficiency.
The company's confidence in navigating industry challenges, coupled with initiatives to drive value and improve patient outcomes, underpin its optimistic outlook for the future.
With a clear focus on growth drivers like Medicare Advantage admissions and revenue per equivalent admission, HCA Healthcare is poised for a promising year ahead.

HCA Healthcare posts robust Q1 earnings, eyes sustained growth opportunities

HCA Healthcare's Q1 2024 performance reflects strong financial results and operational efficiency, supported by favorable same-facility volumes and effective cost management. While facing challenges in outpatient cases, the company is well-positioned to capitalize on opportunities for growth.
Strategic investments in infrastructure, technology, and campus integration are strengthening HCA Healthcare's operational capabilities and market positioning. Monitoring Medicaid statuses and potential procedure rebounds are key focus areas for the company.

HCA Healthcare reports robust Q2 earnings amidst market challenges

HCA Healthcare's Q2 2024 performance reflects strong financial growth, driven by increased revenues and improved margins.
While challenges like managing capital expenditures persist, opportunities in payer mix optimization and market demand offer avenues for further growth.
The company's ability to navigate evolving market dynamics and capitalize on strategic opportunities will be key to sustaining its positive momentum.

HCA Healthcare reports resilient Q3 results amid hurricane challenges

HCA Healthcare's Q3 performance showcased resilience amidst hurricane challenges, with strong volume and revenue growth.
Investments in network expansion and technology underscore the company's commitment to quality care and operational efficiency.
While challenges from hurricanes persist, HCA Healthcare sees opportunities for earnings growth and value creation in the near future.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

HCA Healthcare (HCA) reachead $328.86 at the closing of the latest trading day, reflecting a -0.49% change compared to its last close.

HCA Healthcare (HCA) Stock Slides as Market Rises: Facts to Know Before You Trade

Alibaba

GEN Restaurant Group Inc

The latest filing detailing the stock holdings of the famous investor who predicted the 2008 crash – Michael Burry of “The Big Short” fame – published in mid-February covering the final trimester of 2023 was filled with interesting updates and revelations.

This ‘Big Short' Michael Burry stock is up 50% in a week

Vertex Pharmaceuticals

Vertex Pharmaceuticals is still making progress in its core area while diversifying its lineup. HCA Healthcare's entrenched position in its industry will help it benefit from long-term trends.

2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Is HCA (HCA) a Buy as Wall Street Analysts Look Optimistic?

JD.com

Oracle

Michael Burry's stock market activities have been a major point of interest for investors ever since he made it big with a well-placed bet ahead of the 2008 crisis, which has since solidified its place in history as “ The Big Short .”

Here's how Michael Burry's stock portfolio is performing so far

HCA Healthcare (HCA) reachead $323.55 at the closing of the latest trading day, reflecting a +0.72% change compared to its last close.

HCA Healthcare (HCA) Rises Yet Lags Behind Market: Some Facts Worth Knowing

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Dr. Monique Butler has been appointed president of Graduate Medical Education, effective March 1, 2024. Dr. Butler succeeds Dr. Bruce Deighton who will retire from HCA Healthcare later in 2024. In her new role, Dr. Butler is responsible for the enterprise-wide leadership of HCA Healthcare's Graduate Medical Education (GME) strategy, quality and operations, i.

HCA Healthcare Names Dr. Monique Butler as President of Graduate Medical Education

Apple

DaVita

Alphabet

Progressive

Tesla

Although the stock market has rallied almost non-stop since the start of the year, cracks are beginning to form that indicate a correction may be nearing. Not that I am sounding the alarm for some severe bear market, but rather I would not be surprised to see a garden variety pullback of 5-10% over the next month or so.

Market Leaders Rolling Over: Time to Rotate into Defensive Stocks?

HCA (HCA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

HCA Healthcare, Inc. (HCA) is Attracting Investor Attention: Here is What You Should Know

Iron Mountain

Suzano S.A. - ADR

Tapestry

W. R. Berkley

Iron Mountain (IRM), Suzano (SUZ), Tapestry (TPR), HCA Healthcare (HCA) and W. R. Berkley (WRB) are some of the stocks with high ROE to profit from as technology sector drags the broader index down.

Buy 5 High ROE Stocks as Markets Slide on Tech-Sector Woes

The media is making a lot out of Scion Asset Management's latest filings, but don't read too much into the chatter. Mr. Burry was right to be worried about a market correction in 2023, and shifting to a bullish stance is suitable for 2024; it's not smart to fight the market.

Michael Burry's New Stock Picks That You Might Want To Buy

HCA Healthcare's (HCA) growing equivalent admissions are supporting performance.

HCA Healthcare (HCA) Rises 24.8% in a Year: More Room to Run?

The latest trading day saw HCA Healthcare (HCA) settling at $314.08, representing a +0.67% change from its previous close.

Why the Market Dipped But HCA Healthcare (HCA) Gained Today

Tenet Healthcare

Universal Health Services

Following a careful analysis of the Zacks Medical-Hospital industry, we advise focusing on companies like HCA, UHS and THC.

3 Stocks Worth a Deeper Dive in the Thriving Hospital Industry

NASHVILLE--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it has been recognized as one of the 2024 World's Most Ethical Companies by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. HCA Healthcare has been recognized 14 times and is one of only four honorees in the Healthcare Providers category this year. “Being named as one of the World's Most Ethical companies for the 1.

HCA Healthcare Named as One of the 2024 World's Most Ethical Companies by Ethisphere

One Dow Jones Industrial Average heavyweight is a health care stock this trading expert says is not to be ignored. But is its peer a better bet?

This Dow Jones Stock Is Not To Be Ignored. Why Doing So Would Be 'Misguided.

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), is scheduled to present at the following healthcare conference: March 12, 2024 at 10:00 am ET at the 34th Oppenheimer Annual Virtual Healthcare Conference. A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company's website, www.hcahealthcare.com. Dates and times may be subject to change, please check the conferenc.

HCA Healthcare, Inc. to Present at March Healthcare Conference

HCA (HCA) reported earnings 30 days ago. What's next for the stock?

Why Is HCA (HCA) Up 2.4% Since Last Earnings Report?

HCA Healthcare's (HCA) Sarah Cannon Cancer Institute adopts a new outpatient model for CAR T-cell therapy patients.

HCA Healthcare (HCA) Drives Efficiency With New Outpatient Model

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the Sarah Cannon Cancer Institute (SCCI) of HCA Healthcare has successfully established an integrated management process that safely transitioned more than 75% of HCA Healthcare's CAR T-cell therapy patients into an outpatient setting for monitoring. The program model resulted in more than 1,200 hospital bed days saved for the first 100 patients of the progr.

HCA Healthcare's Sarah Cannon Cancer Institute Implements New Outpatient Model for CAR T-cell Therapy

General Motors

NVIDIA

Palo Alto Networks

Super Micro Computer

The stock market has moved aggressively higher since the start of the year with the S&P 500 gaining 4.6% YTD and the Nasdaq 100 5.2%. While there is nothing inherently wrong with the market showing such strength, there are a few concerning developments brewing that may lead to at least a minor correction in the coming weeks.

Markets Appear Vulnerable: Hideout in these 3 Top Ranked Defensive Stocks

Amazon

AppLovin Corp

Royal Caribbean Cruises

We have narrowed our search to five growth stocks that have solid upside left for 2024. These are: AMZN, RCL, PGR, HCA, APP.

5 Must-Buy Growth Stocks for Sparkling Returns in Near Future

Arch Capital

America Movil SAB de CV

Carlisle Companies

Arch Capital (ACGL), Suzano (SUZ), Carlisle (CSL), HCA Healthcare (HCA) and America Movil (AMX) are some of the stocks with high ROE to profit from as markets swing wildly.

5 High ROE Stocks to Bet on as Markets Sway Whimsically

Booking Hlds

Citigroup

Crescent Energy

Euronav

Hudson Pacific Properties

Nexstar Media Group

Stellantis N.V. 

Michael Burry, the infamous investor known for being one of the first to bet against the housing market ahead of the 2008 financial crisis, made some big moves in Q4 2023. Indeed, Burry made hundreds of millions for his firm, Scion Asset Management, as subprime mortgage bonds started failing in the mid-2000s.

11 Stocks Michael Burry Was Buying and Selling in Q4

Dell Technologies

At the start of 2024, traders were pricing in an incredibly dovish six rate cuts this year, but not anymore. After strong economic growth, robust labor, and hotter than forecasted inflation data rolled in, expectations have fallen to just four cuts now.

News for HCA Healthcare Stock (HCA)